home / stock / numif / numif articles

NUMIF Articles, Numinus Wellness Inc.

Stock Information
Company Name: Numinus Wellness Inc.
Stock Symbol: NUMIF
Market: OTC
Website: numinus.ca
Menu
NUMIF NUMIF Quote NUMIF Short NUMIF News NUMIF Articles NUMIF Message Board
Get NUMIF Alerts

News, Short Squeeze, Breakout and More Instantly...
Psychedelics-Focused Numinus Plans To Leverage This AI Technology Via New Strategic Acquisition | Benzinga

Psychedelics-focused mental healthcare company Numinus Wellness Inc. (TSX:NUMI) (OTCQX:NUMIF) (FSE: LR23) plans to take over MedBright AI Investmen...
MedBright AI Announces Strategic Acquisition by Numinus Wellness | Benzinga

Plans name change to "Numinus Intelligence" leveraging its current revenue generating operations to AI-enable mental health clinics across the US ...

Numinus Wellness Q2 2024 Revenue Declines Amid Clinic Reshuffling And Expected Industry Trends | Benzinga

Psychedelics healthcare company Numinus Wellness (OTCQX:NUMIF) shared its unaudited, condensed and consolidated interim financial results for the t...

Two Top Biotechs Forge MDMA Supply Deals For Clinical Research | Benzinga

Two separate deals hit the wires on Tuesday. One is PharmAla Biotech's (OTC:MDXXF) with Numinus Wellness (OTC:NUMIF) for a group therapy model...
PharmAla Biotech Signs Sale Agreement with Numinus | Benzinga

TORONTO, March 26, 2024 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. ("PharmAla" or the "Company") (CSE:MDMA, OTC:MDXXF), a biotechnology ...

Utah Hospitals Will Soon Provide Psilocybin And MDMA Therapy For Mental Health Conditions | Benzinga

Providers at Utah's two largest healthcare systems may now treat patients with psilocybin and MDMA as part of a pilot program created by a pro...

Numinus Wellness Inc. Announces $6 Million Bought Deal Public Offering with Leads Orders from MAPS and Integrated V.C. | Benzinga

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINA...
Numinus Wellness Continues Tight Expense Management With Strategic Reviews Underway | Benzinga

Psychedelics mental healthcare company Numinus Wellness (OTCQX: NUMIF) posted its financial results for the three months ended Nov. 30, 2023. ...

30 Psychedelics Executives, Scientists & Influencers To Watch In 2024 And Beyond | Benzinga

The emerging psychedelics industry is expanding rapidly across the globe. With research demonstrating promising therapeutic potential for substance...

Psyched: Defense Dept.'s Ketamine Trial, Cybin's Psilocybin, Metabolic Disorders, Reform Update And More | Benzinga

Defense Dept. Funds Ketamine Study For PTSD Treatment  A DOD Health Agency-funded adaptive platform trial for alternative treatments for ...
Next 10